{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T22:06:40Z","timestamp":1783030000929,"version":"3.54.6"},"reference-count":54,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.jpsychires.2010.07.011","type":"journal-article","created":{"date-parts":[[2010,9,11]],"date-time":"2010-09-11T08:16:34Z","timestamp":1284192994000},"page":"539-547","source":"Crossref","is-referenced-by-count":46,"title":["Biochemical studies in Normal Pressure Hydrocephalus (NPH) patients: Change in CSF levels of amyloid precursor protein (APP), amyloid-beta (A\u03b2) peptide and phospho-tau"],"prefix":"10.1016","volume":"45","author":[{"given":"Balmiki","family":"Ray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricio F.","family":"Reyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debomoy K.","family":"Lahiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpsychires.2010.07.011_bib1","first-page":"36","article-title":"Image processing with ImageJ","volume":"11","author":"Abramoff","year":"2004","journal-title":"Biophotonics International"},{"key":"10.1016\/j.jpsychires.2010.07.011_bib2","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJM196507152730301","article-title":"Symptomatic occult hydrocephalus with \u201cNormal\u201d cerebrospinal-fluid pressure. A treatable syndrome","volume":"273","author":"Adams","year":"1965","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.jpsychires.2010.07.011_bib3","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/jnr.22172","article-title":"Memantine lowers amyloid-beta peptide levels in neuronal cultures and in APP\/PS1 transgenic mice","volume":"88","author":"Alley","year":"2009","journal-title":"Journal of Neuroscience Research"},{"key":"10.1016\/j.jpsychires.2010.07.011_bib4","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1001\/archneur.56.6.673","article-title":"Cerebrospinal fluid beta-amyloid(1\u201342) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease","volume":"56","author":"Andreasen","year":"1999","journal-title":"Archives of Neurology"},{"key":"10.1016\/j.jpsychires.2010.07.011_bib5","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S1474-4422(03)00530-1","article-title":"CSF markers for incipient Alzheimer\u2019s disease","volume":"2","author":"Blennow","year":"2003","journal-title":"Lancet Neurology"},{"key":"10.1016\/j.jpsychires.2010.07.011_bib6","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF02815140","article-title":"Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?","volume":"26","author":"Blennow","year":"1995","journal-title":"Molecular and Chemical Neuropathology"},{"key":"10.1016\/j.jpsychires.2010.07.011_bib7","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.mehy.2004.03.029","article-title":"Unifying concept for Alzheimer\u2019s disease, vascular dementia and normal pressure hydrocephalus \u2013 a hypothesis","volume":"63","author":"Chakravarty","year":"2004","journal-title":"Medical Hypotheses"},{"key":"10.1016\/j.jpsychires.2010.07.011_bib8","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3233\/JAD-2007-12308","article-title":"Binding of proteases to fibrillar amyloid-beta protein and its inhibition by Congo red","volume":"12","author":"Chander","year":"2007","journal-title":"Journal of Alzheimer\u2019s Disease"},{"issue":"Suppl. 1","key":"10.1016\/j.jpsychires.2010.07.011_bib9","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1016\/j.surneu.2008.08.079","article-title":"Normal pressure hydrocephalus: cerebral hemodynamic, metabolism measurement, discharge score, and long-term outcome","volume":"70","author":"Chen","year":"2008","journal-title":"Surgical Neurology"},{"key":"10.1016\/j.jpsychires.2010.07.011_bib10","doi-asserted-by":"crossref","first-page":"13170","DOI":"10.1073\/pnas.93.23.13170","article-title":"Evidence that the 42- and 40-amino acid forms of amyloid beta protein are generated from the beta-amyloid precursor protein by different protease activities","volume":"93","author":"Citron","year":"1996","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.jpsychires.2010.07.011_bib11","doi-asserted-by":"crossref","first-page":"476","DOI":"10.7326\/0003-4819-109-6-476","article-title":"The reversible dementias: do they reverse?","volume":"109","author":"Clarfield","year":"1988","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.jpsychires.2010.07.011_bib12","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/BF03402076","article-title":"[alpha]-Secretase ADAM10 as well as [alpha]APPs is reduced in platelets and CSF of Alzheimer disease patients","volume":"8","author":"Colciaghi","year":"2002","journal-title":"Molecular Medicine"},{"key":"10.1016\/j.jpsychires.2010.07.011_bib13","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/ana.21559","article-title":"Decreased cerebrospinal fluid Abeta(42) correlates with brain atrophy in cognitively normal elderly","volume":"65","author":"Fagan","year":"2009","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.jpsychires.2010.07.011_bib14","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1001\/archneur.64.3.noc60123","article-title":"Cerebrospinal fluid tau\/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults","volume":"64","author":"Fagan","year":"2007","journal-title":"Archives of Neurology"},{"key":"10.1016\/j.jpsychires.2010.07.011_bib15","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/jcp.20602","article-title":"Cerebrospinal fluid tau, A beta, and phosphorylated tau protein for the diagnosis of Alzheimer\u2019s disease","volume":"208","author":"Formichi","year":"2006","journal-title":"Journal of Cellular Physiology"},{"key":"10.1016\/j.jpsychires.2010.07.011_bib16","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1523\/JNEUROSCI.5170-04.2005","article-title":"Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model","volume":"25","author":"Fryer","year":"2005","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.jpsychires.2010.07.011_bib17","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1136\/jnnp.68.6.778","article-title":"Alzheimer\u2019s disease comorbidity in normal pressure hydrocephalus: prevalence and shunt response","volume":"68","author":"Golomb","year":"2000","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"10.1016\/j.jpsychires.2010.07.011_bib18","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.ncl.2007.03.004","article-title":"Normal pressure hydrocephalus","volume":"25","author":"Graff-Radford","year":"2007","journal-title":"Neurologic Clinics"},{"key":"10.1016\/j.jpsychires.2010.07.011_bib19","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1016\/S0002-9440(10)65494-6","article-title":"Tau pathology generated by overexpression of tau","volume":"155","author":"Grundke-Iqbal","year":"1999","journal-title":"The American Journal of Pathology"},{"key":"10.1016\/j.jpsychires.2010.07.011_bib20","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.1073\/pnas.83.13.4913","article-title":"Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology","volume":"83","author":"Grundke-Iqbal","year":"1986","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.jpsychires.2010.07.011_bib21","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.mehy.2006.01.029","article-title":"Theoretical considerations on the pathophysiology of normal pressure hydrocephalus (NPH) and NPH-related dementia","volume":"67","author":"Hamlat","year":"2006","journal-title":"Medical Hypotheses"},{"key":"10.1016\/j.jpsychires.2010.07.011_bib22","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/sj.mp.4001473","article-title":"Value of CSF beta-amyloid1-42 and tau as predictors of Alzheimer\u2019s disease in patients with mild cognitive impairment","volume":"9","author":"Hampel","year":"2004","journal-title":"Molecular Psychiatry"},{"key":"10.1016\/j.jpsychires.2010.07.011_bib23","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S1474-4422(06)70355-6","article-title":"Association between CSF biomarkers and incipient Alzheimer\u2019s disease in patients with mild cognitive impairment: a follow-up study","volume":"5","author":"Hansson","year":"2006","journal-title":"Lancet Neurology"},{"key":"10.1016\/j.jpsychires.2010.07.011_bib24","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1055\/s-2003-40733","article-title":"Brain biopsy prior to treatment of Alzheimer\u2019s disease","volume":"46","author":"Holm","year":"2003","journal-title":"Minimally Invasive Neurosurgery"},{"key":"10.1016\/j.jpsychires.2010.07.011_bib25","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0140-6736(86)92134-3","article-title":"Defective brain microtubule assembly in Alzheimer\u2019s disease","volume":"2","author":"Iqbal","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.jpsychires.2010.07.011_bib26","doi-asserted-by":"crossref","first-page":"222","DOI":"10.2176\/nmc.44.222","article-title":"Clinical guidelines for idiopathic normal pressure hydrocephalus","volume":"44","author":"Ishikawa","year":"2004","journal-title":"Neurologia Medico-chirurgica"},{"key":"10.1016\/j.jpsychires.2010.07.011_bib27","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1468-1331.2006.01593.x","article-title":"Cerebrospinal fluid tau, phospho-tau181 and beta-amyloid1-42 in idiopathic normal pressure hydrocephalus: a discrimination from Alzheimer\u2019s disease","volume":"14","author":"Kapaki","year":"2007","journal-title":"European Journal of Neurology"},{"key":"10.1016\/j.jpsychires.2010.07.011_bib28","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1196\/annals.1352.008","article-title":"Amyloid, cholinesterase, melatonin, and metals and their roles in aging and neurodegenerative diseases","volume":"1056","author":"Lahiri","year":"2005","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/j.jpsychires.2010.07.011_bib29","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2174\/1389450033346957","article-title":"A critical analysis of new molecular targets and strategies for drug developments in Alzheimer\u2019s disease","volume":"4","author":"Lahiri","year":"2003","journal-title":"Current Drug Targets"},{"issue":"Pt 2","key":"10.1016\/j.jpsychires.2010.07.011_bib30","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1242\/jcs.102.2.227","article-title":"Expression of tau protein in non-neuronal cells: microtubule binding and stabilization","volume":"102","author":"Lee","year":"1992","journal-title":"Journal of Cell Science"},{"key":"10.1016\/j.jpsychires.2010.07.011_bib31","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1001\/archneur.65.10.noc80013","article-title":"Assessment of beta-amyloid in a frontal cortical brain biopsy specimen and by positron emission tomography with carbon 11-labeled Pittsburgh Compound B","volume":"65","author":"Leinonen","year":"2008","journal-title":"Archives of Neurology"},{"key":"10.1016\/j.jpsychires.2010.07.011_bib32","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1373\/clinchem.2005.058776","article-title":"Effect of sample collection tubes on cerebrospinal fluid concentrations of tau proteins and amyloid beta peptides","volume":"52","author":"Lewczuk","year":"2006","journal-title":"Clinical Chemistry"},{"key":"10.1016\/j.jpsychires.2010.07.011_bib33","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/mp.2008.84","article-title":"Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer's disease: a multicenter study","volume":"15","author":"Lewczuk","year":"2010","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.jpsychires.2010.07.011_bib34","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00702-003-0075-x","article-title":"Immunoreactivities of amyloid beta peptide((1\u201342)) and total tau protein in lumbar cerebrospinal fluid of patients with normal pressure hydrocephalus","volume":"111","author":"Lins","year":"2004","journal-title":"Journal of Neural Transmission"},{"key":"10.1016\/j.jpsychires.2010.07.011_bib35","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1159\/000156487","article-title":"Analysis of cerebrospinal fluid of Alzheimer patients. Biomarkers and toxic properties","volume":"82","author":"Marksteiner","year":"2008","journal-title":"Pharmacology"},{"key":"10.1016\/j.jpsychires.2010.07.011_bib36","first-page":"201","article-title":"Clinicopathologic correlations of soluble amyloid beta-protein precursor in cerebrospinal fluid in patients with Alzheimer disease and controls","volume":"11","author":"Peskind","year":"1997","journal-title":"Alzheimer Disease and Associated Disorders"},{"key":"10.1016\/j.jpsychires.2010.07.011_bib37","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1001\/archneur.1996.00550020105022","article-title":"Cerebrospinal fluid concentrations of soluble amyloid beta-protein and apolipoprotein E in patients with Alzheimer\u2019s disease: correlations with amyloid load in the brain","volume":"53","author":"Pirttila","year":"1996","journal-title":"Archives of Neurology"},{"key":"10.1016\/j.jpsychires.2010.07.011_bib38","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.jneumeth.2009.08.018","article-title":"Molecular and immunocytochemical characterization of primary neuronal cultures from adult rat brain: differential expression of neuronal and glial protein markers","volume":"184","author":"Ray","year":"2009","journal-title":"Journal of Neuroscience Methods"},{"key":"10.1016\/j.jpsychires.2010.07.011_bib39","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.coph.2009.06.012","article-title":"Neuroinflammation in Alzheimer\u2019s disease: different molecular targets and potential therapeutic agents including curcumin","volume":"9","author":"Ray","year":"2009","journal-title":"Current Opinion in Pharmacology"},{"key":"10.1016\/j.jpsychires.2010.07.011_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1385\/NMM:1:1:1","article-title":"Advances in the cellular and molecular biology of the beta-amyloid protein in Alzheimer\u2019s disease","volume":"1","author":"Sambamurti","year":"2002","journal-title":"Neuromolecular Medicine"},{"key":"10.1016\/j.jpsychires.2010.07.011_bib41","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1212\/WNL.52.3.547","article-title":"CSF beta-amyloid, cognition, and APOE genotype in Alzheimer\u2019s disease","volume":"52","author":"Samuels","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.jpsychires.2010.07.011_bib42","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1749-6632.2000.tb05554.x","article-title":"Toward a comprehensive theory for Alzheimer\u2019s disease. Hypothesis: Alzheimer\u2019s disease is caused by the cerebral accumulation and cytotoxicity of amyloid beta-protein","volume":"924","author":"Selkoe","year":"2000","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/j.jpsychires.2010.07.011_bib43","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1006\/abbi.1998.0813","article-title":"Phosphorylation of tau at both Thr 231 and Ser 262 is required for maximal inhibition of its binding to microtubules","volume":"357","author":"Sengupta","year":"1998","journal-title":"Archives of Biochemistry and Biophysics"},{"key":"10.1016\/j.jpsychires.2010.07.011_bib44","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0304-3940(99)00929-5","article-title":"Levels of alpha- and beta-secretase cleaved amyloid precursor protein in the cerebrospinal fluid of Alzheimer\u2019s disease patients","volume":"278","author":"Sennvik","year":"2000","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.jpsychires.2010.07.011_bib45","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/PL00007412","article-title":"Morphological alterations of the choroid plexus in late-onset Alzheimer\u2019s disease","volume":"99","author":"Serot","year":"2000","journal-title":"Acta Neuropathologica"},{"key":"10.1016\/j.jpsychires.2010.07.011_bib46","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1093\/brain\/awh178","article-title":"Normal pressure hydrocephalus (NPH): ischaemia, CSF stagnation or both","volume":"127","author":"Silverberg","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.jpsychires.2010.07.011_bib47","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/S1474-4422(03)00487-3","article-title":"Alzheimer\u2019s disease, normal-pressure hydrocephalus, and senescent changes in CSF circulatory physiology: a hypothesis","volume":"2","author":"Silverberg","year":"2003","journal-title":"Lancet Neurology"},{"key":"10.1016\/j.jpsychires.2010.07.011_bib48","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1159\/000241881","article-title":"Evaluation of cerebrospinal fluid tau\/beta-amyloid(42) ratio as diagnostic markers for Alzheimer disease","volume":"62","author":"Smach","year":"2009","journal-title":"European Neurology"},{"key":"10.1016\/j.jpsychires.2010.07.011_bib49","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/978-3-7091-6467-9_12","article-title":"The cytoskeleton in Alzheimer disease","volume":"53","author":"Terry","year":"1998","journal-title":"Journal of Neural Transmission: Supplementum"},{"key":"10.1016\/j.jpsychires.2010.07.011_bib50","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1073\/pnas.89.7.2551","article-title":"Decreased levels of soluble amyloid beta-protein precursor in cerebrospinal fluid of live Alzheimer disease patients","volume":"89","author":"Van Nostrand","year":"1992","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.jpsychires.2010.07.011_bib51","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00702-008-0177-6","article-title":"Combined CSF tau, p-tau181 and amyloid-beta 38\/40\/42 for diagnosing Alzheimer\u2019s disease","volume":"116","author":"Welge","year":"2009","journal-title":"Journal of Neural Transmission"},{"key":"10.1016\/j.jpsychires.2010.07.011_bib52","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/(SICI)1099-1166(199701)12:1<101::AID-GPS469>3.0.CO;2-R","article-title":"Limitations of the mini-mental state examination in diagnosing dementia in general practice","volume":"12","author":"Wind","year":"1997","journal-title":"International Journal of Geriatric Psychiatry"},{"key":"10.1016\/j.jpsychires.2010.07.011_bib53","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2174\/156720509787313943","article-title":"The Valsalva maneuver and Alzheimer\u2019s disease: is there a link?","volume":"6","author":"Wostyn","year":"2009","journal-title":"Current Alzheimer Research"},{"key":"10.1016\/j.jpsychires.2010.07.011_bib54","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.brainres.2008.02.060","article-title":"Plasma antibodies to Abeta40 and Abeta42 in patients with Alzheimer\u2019s disease and normal controls","volume":"1219","author":"Xu","year":"2008","journal-title":"Brain Research"}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395610002232?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395610002232?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,9]],"date-time":"2021-11-09T15:45:16Z","timestamp":1636472716000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395610002232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S0022395610002232"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2010.07.011","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}